Healthcare Stocks
Healthcare covers pharmaceuticals, biotech, medical devices, managed care, and hospitals. Patent cliffs, regulatory risk, and binary clinical outcomes distort reported earnings, so we lean on cash-based valuation (Price/FCF, EV/EBITDA) and multi-year revenue durability when ranking this sector. Biotech pre-revenue names often screen poorly on Value — that's by design.
Top 50 Healthcare Stocks by StockRank
| # | Ticker | Company | Mkt Cap | Score | Q | V | M |
|---|---|---|---|---|---|---|---|
| 1 | ASCN.SW | Ascom Holding AG | $252M | 100 | 72 | 71 | 80 |
| 2 | 2877.HK | China Shineway Pharmaceutical Group Limited | $813M | 100 | 74 | 84 | 55 |
| 3 | CGEN | Compugen Ltd. | $265M | 100 | 85 | 64 | 64 |
| 4 | PHIL.MI | Philogen S.p.A. | $1.1B | 100 | 92 | 70 | 51 |
| 5 | T14.SI | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited | $3.3B | 100 | 81 | 80 | 52 |
| 6 | 0157.KL | Focus Point Holdings Berhad | $83M | 100 | 75 | 78 | 57 |
| 7 | 3600.HK | Modern Dental Group Limited | $688M | 100 | 79 | 77 | 56 |
| 8 | CPRX | Catalyst Pharmaceuticals, Inc. | $3.8B | 100 | 87 | 45 | 78 |
| 9 | OGN | Organon & Co. | $3.5B | 100 | 61 | 61 | 89 |
| 10 | BMY | Bristol-Myers Squibb Company | $121.4B | 100 | 70 | 62 | 76 |
| 11 | DVA | DaVita Inc. | $12.7B | 100 | 62 | 64 | 82 |
| 12 | PRM.MC | Prim, S.A. | $261M | 100 | 76 | 72 | 60 |
| 13 | 2219.HK | Chaoju Eye Care Holdings Limited | $240M | 100 | 66 | 81 | 58 |
| 14 | BOI.PA | Boiron SA | $550M | 99 | 73 | 78 | 54 |
| 15 | LNTH | Lantheus Holdings, Inc. | $6.7B | 99 | 76 | 43 | 85 |
| 16 | PBYI | Puma Biotechnology, Inc. | $360M | 99 | 77 | 63 | 64 |
| 17 | EXEL | Exelixis, Inc. | $12.6B | 99 | 87 | 45 | 72 |
| 18 | RX.V | BioSyent Inc. | $116M | 99 | 88 | 47 | 66 |
| 19 | IRWD | Ironwood Pharmaceuticals, Inc. | $645M | 99 | 67 | 72 | 62 |
| 20 | 000423.SZ | Dong-E-E-Jiao Co., Ltd. | $4.7B | 99 | 85 | 61 | 53 |
| 21 | DR.TO | Medical Facilities Corporation | $227M | 99 | 57 | 66 | 76 |
| 22 | 1720.TW | Standard Chemical & Pharmaceutical Co., Ltd. | $353M | 99 | 72 | 73 | 54 |
| 23 | BION.SW | BB Biotech AG | $3.1B | 99 | 66 | 76 | 57 |
| 24 | NUTX | Nutex Health Inc. | $818M | 99 | 79 | 69 | 51 |
| 25 | VMD | Viemed Healthcare, Inc. | $370M | 99 | 73 | 54 | 71 |
| 26 | DRW8.DE | Drägerwerk AG & Co. KGaA | $1.6B | 99 | 67 | 80 | 51 |
| 27 | 1707.TW | Grape King Bio Ltd | $485M | 99 | 80 | 76 | 41 |
| 28 | 600351.SS | Yabao Pharmaceutical Group Co., Ltd | $657M | 99 | 80 | 75 | 43 |
| 29 | LIK.DE | LIMES Schlosskliniken AG | $175M | 99 | 73 | 38 | 86 |
| 30 | 6782.TW | Visco Vision Inc. | $383M | 98 | 77 | 62 | 57 |
| 31 | 6823.T | Rion Co., Ltd. | $288M | 98 | 67 | 69 | 60 |
| 32 | SDI.AX | SDI Limited | $114M | 98 | 75 | 65 | 57 |
| 33 | 4671.T | FALCO HOLDINGS Co., Ltd. | $159M | 98 | 69 | 75 | 52 |
| 34 | 7575.T | Japan Lifeline Co., Ltd. | $573M | 98 | 78 | 73 | 45 |
| 35 | INVA | Innoviva, Inc. | $1.7B | 98 | 76 | 65 | 55 |
| 36 | 096760.KS | JW Holdings Corporation | $179M | 98 | 61 | 64 | 70 |
| 37 | BIIB | Biogen Inc. | $28.6B | 98 | 65 | 56 | 74 |
| 38 | DRW3.DE | Drägerwerk AG & Co. KGaA | $2.0B | 98 | 67 | 75 | 53 |
| 39 | 600566.SS | Hubei Jumpcan Pharmaceutical Co., Ltd. | $3.8B | 98 | 73 | 63 | 58 |
| 40 | INCY | Incyte Corporation | $19.4B | 98 | 86 | 47 | 61 |
| 41 | M12.DE | M1 Kliniken AG | $414M | 98 | 72 | 66 | 56 |
| 42 | AUPH | Aurinia Pharmaceuticals Inc. | $2.0B | 98 | 81 | 53 | 60 |
| 43 | PFE | Pfizer Inc. | $147.6B | 98 | 58 | 69 | 67 |
| 44 | SNY | Sanofi | $105.9B | 98 | 61 | 75 | 58 |
| 45 | UTMD | Utah Medical Products, Inc. | $205M | 98 | 77 | 55 | 61 |
| 46 | GUD.TO | Knight Therapeutics Inc. | $607M | 98 | 57 | 49 | 87 |
| 47 | CRRX.TO | CareRx Corporation | $165M | 98 | 62 | 68 | 62 |
| 48 | 1612.HK | Vincent Medical Holdings Limited | $73M | 98 | 69 | 84 | 40 |
| 49 | TSTL.L | TRISTEL PLC ORD 1P | $248M | 97 | 84 | 45 | 63 |
| 50 | RO.SW | Roche Holding AG | $344.6B | 97 | 73 | 46 | 72 |
Other Sectors
Technology
Software, semiconductors, cloud, and platform businesses ranked by Quality, Value, and Momentum.
Financial Services
Banks, insurers, asset managers, and exchanges ranked on Quality, Value, and Momentum.
Consumer Cyclical
Autos, retail, travel, and apparel — cyclical consumer names ranked by MoatMap.
Consumer Defensive
Food, beverage, household products, and discount retail — stable demand businesses.
Industrials
Aerospace, machinery, defence, transportation, and logistics ranked by Quality, Value, and Momentum.
Energy
Oil & gas, refining, pipelines, and energy services ranked by MoatMap.
Basic Materials
Mining, metals, chemicals, and building materials ranked on Quality, Value, and Momentum.
Utilities
Regulated electric, gas, water, and renewable utilities ranked by MoatMap.
Real Estate
REITs across residential, commercial, industrial, and data centre property ranked by MoatMap.
Communication Services
Telecom, media, interactive entertainment, and internet platforms ranked by MoatMap.